[en] The scientific information about melanoma is on the rise. It has a direct impact on the diagnostic acuteness and on the therapeutic management. The most recent aspects of the utmost importance are presented. The concept of the duality between fast-growing (high malignancy) and slow-growing (reduced malignancy) melanoma is stressed. A new international multicentric approach using adjuvant therapy for stage III melanomas involves the clinical oncology department of the CHU of Liege. It concerns a targeted immunotherapy directed to the Mage A3 protein.
Disciplines :
Dermatology
Author, co-author :
Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Quatresooz, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Rorive, Andrée ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Language :
French
Title :
Le melanome cutane: innovations conceptuelles et therapeutiques, fruit de la recherche translationnelle.
Alternative titles :
[en] Malignant melanoma: conceptual and therapeutic innovations based on translational research
Publication date :
2008
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Piérard-Franchimont C, Burg G, Grosshans E, et al. - Prévalence des cancers de la peau en région mosane et dans des pays européens de même latitude. Rev Med Liège, 1989, 44, 541-545.
Brochez L, Verhaeghe E, Bleyen L, et al. - Underregistration of melanoma in Belgium : an analysis. Melanoma Res, 1999, 9, 413-418.
Piérard-Franchimont C, Uhoda I, Piérard GE. - Cutaneous cancers in the Mosan region and Ardennes of Belgium. Dermatology, 1999, 198, 187-191.
Quatresooz P, Uhoda I, Fumal I, et al. - Revisiting the gender-linked melanoma burden. Dermatology, 2004, 209, 197-201.
Uhoda I, Quatresooz P, Fumal I, et al. - Updating trends in cutaneous cancers in south-east Belgium. Oncol Rep, 2004, 12, 111-114.
Quatresooz P, Piérard-Franchimont C, Piérard GE. - Space-time clustering and seasonality in diagnosing skin cancers in Wallonia (South East Belgium). Dermatology, 2008, 217, 48-51.
Naeyaert JM. - The melanoma burden in Belgium : premature morbidity and mortality make melanoma a considerable health problem. Melanoma Res, 1999, 9, 614-618.
Lehembre S, Carvalho P, Young P, et al. - Prise en charge des malades en fin de vie dans un service de dermatologie. Ann Dermatol Venereol, 2006, 133, 967-970.
Grange F. - Quoi de neuf en cancérologie cutanée ? Ann Dermatol Venereol, 2007, 134, 8 S53-8 S63.
Quatresooz P, Arrese JE, Piérard-Franchimont C, Piérard GE. - Immunohistochemical aid at risk stratification of melanocytic neoplasms. Int J Oncol, 2004, 24, 211-216.
Ciaessens N, Piérard GE, Piérard-Franchimont C, et al. - Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement. Melanoma Res, 2005, 15, 107-110.
Quatresooz P, Hustinx R, Piérard-Franchimont C, Piérard GE. - Le mélanome cutané dans une perspective liégeoise. Actualisation de son épidémiologie et avancées diagnostiques. Rev Med Liège, 2007, 62, S52-S55.
Quatresooz P, Piérard-Franchimont C, Piérard GE. - Highlighting the immunohistochemical profile of melanocytomas. Oncol Rep, 2008, 19, 1367-1372.
Quatresooz P, Piérard-Franchimont C, Rorive A, et al. - Molecular histology on the diagnostic cutting edge between malignant melanomas and melanocytomas. J Eur Acad Dermatol Venereol, sous presse.
Piérard GE, Scheen A. - Glossaire initiatique aux recherches cliniques. Rev Med Liège, 2006, 61, 190-194.
Karlsson PM, Fredrikson M. - Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002 : the increasing trend is broken. Int J Cancer, 2007, 121, 323-328.
Jemal A, Siegel R, Ward, E, et al. - Cancer statistics, 2007. CA Cancer J Clin, 2007, 57, 43-66.
Lipsker D, Engel F, Cribier B, et al. - Trends in epidemiology suggest three different types of melanoma. Arch Dermatol, 2007, 157, 338-343.
Clark NL, Shin DB, Troxel AB, et al. - Association between the anatomic distribution of melanoma and sex. J Am Acad Dermatol, 2007, 56, 768-773.
Verdaccia A, Francisci S, Brenner H, et al. - Recent cancer survival in Europe : a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol, 2007, 8, 784-796.
Berrino F, De Angelis R, Sant M, et al. - Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99 : results of the EUROCARE-4 study. Lancet Oncol, 2007, 8, 773-778.
Lasithiotakis KG, Leiter U, Eigentier T, et al. - Improvement of survival of patients with cutaneous melanoma in Germany, 1976-2001 : which factors contributed ? Cancer, 2007, 109, 1174-1182.
Piérard GE, Piérard-Franchimont C, Henry C, Lapière M. - The proliferative activity of cells of malignant melanomas. Am J Dermatopathol, 1984, 6, S317-S324.
Lipsker D. - Growth rate, early detection and prevention of melanoma. Melanoma epidemiology revisited and future challenges. Arch Dermatol, 2006, 142, 1638-1640.
Liu W, Dowling JP, Murray WK, et al. - Rate of growth in melanomas. Characteristics and associations of rapidly growing melanoma. Arch Dermatol, 2006, 142, 1551-1558.
Liu W, Kelly JW, Trivett M, et al. - Distinct clinical and pathological features are associated with BRAF mutation in primary melanoma. J Invest Dermatol, 2007, 127, 900-905.
Piérard-Franchimont C, Henry F, Heymans O, Piérard GE. - Vascular retardation in dormant growth-stunted malignant melanomas. Int J Mol Med, 1999, 4, 403-406.
Piérard GE, Piérard-Franchimont C. - Dépistage et diagnostic précoce du mélanome cutané. Rev Med Liège, 1995, 50, 525-529.
Baumert J, Plewig G, Volkenandt M, Schmid-Wendtner MH. - Factors associated with high tumour thickness in patients with melanoma. Br J Dermatol, 2007, 156, 938-944.
Fearfield LA, Larkin JMG, Rowe A, et al. - Expression of p16, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma. Br J Dermatol, 2007, 156, 440-447.
Gimotty PA, Elder DE, Fraker DL, et al. - Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol, 2007, 25, 1129-1134.
Gietema HA, Vuylsteke RJ, de Jonge IA, et al. - Sentinel lymph node investigation in melanoma : detailed analysis of the yield for step sectioning and immunohistochemistry. J Clin Pathol, 2004, 57, 618-620.
Spanknebel K, Coit DG, Bieligk SC, et al. - Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology : recommendations for standardizing pathologic analysis. Am J Surg Pathol, 2005, 29, 305-317.
Johnson TM, Sondak VK, Bichakjian CK, Sabel MS. - The role of sentinel lymph node biopsy for melanoma : evidence assessment. J Am Acad Dermatol, 2007, 54, 19-27.
Zogakis TG, Essner R, Wang HJ, et al. - Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes. Ann Surg Oncol, 2007, 14, 1604-1611.
Satzger I, Völker B, Ghazal MA, et al. - Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology, 2007, 50, 764-772.
Debarbieux S, Duru G, Dalle S, et al. - Sentinel lymph node biopsy in melanoma : a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol, 2007, 157, 58-67.
Van Akkooi AJC, de Wilt JHW, Verhoef C, et al. - Clinical relevance of melanoma micrometastases (< 0,1 mm) in sentinel nodes : are these nodes to be considered negative ? Ann Oncol, 2006, 17, 1578-1585.
Piérard-Franchimont C, Piérard GE. - Comment j'explore... un patient atteint de mélanome : actualisation d'un algorithme. Rev Med Liège, 2006, 61, 837-842.
Quatresooz P, Hustinx R, Piérard-Franchimont C, Piérard GE. - Le mélanome cutané dans une perspective liégeoise. Actualisation de son épidémiologie et avancées diagnostiques. Rev Med Liège, 2007, 62, S52-S55.
Saiag P, Bosquet L, Guillot B, et al. - Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French standards, options and recommendations guidelines. Summary report. Eur J Dermatol, 2007, 17, 325-331.
Eggermont AM, Suciu S, Santinami M, et al. - Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma : final results of EORTC 18991, a randomised phase III trial. Lancet, 2008, 372, 117-126.
Ralph SJ. - An update on malignant melanoma. Vaccine research. Insights into mechanisms for improving the design and potency of melanoma therapeutic vaccines. Am J Clin Dermatol, 2007, 8, 123-141.
